Granite Investment Partners’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.46M Buy
11,098
+99
+0.9% +$53.7K 0.34% 102
2025
Q4
$6.37M Buy
10,999
+1,050
+11% +$594K 0.38% 89
2025
Q3
$4.83M Sell
9,949
-1,149
-10% -$535K 0.27% 115
2025
Q2
$4.5M Sell
11,098
-64
-0.6% -$26.8K 0.22% 118
2025
Q1
$5.55M Buy
11,162
+22
+0.2% +$11.9K 0.28% 108
2024
Q4
$5.8M Sell
11,140
-10,801
-49% -$5.94M 0.25% 113
2024
Q3
$13.6M Sell
21,941
-1,494
-6% -$884K 0.58% 64
2024
Q2
$13M Sell
23,435
-34
-0.1% -$19.5K 0.54% 67
2024
Q1
$13.6M Sell
23,469
-1,243
-5% -$697K 0.52% 70
2023
Q4
$13.1M Sell
24,712
-1,100
-4% -$532K 0.51% 71
2023
Q3
$13.1M Buy
25,812
+480
+2% +$256K 0.55% 68
2023
Q2
$13.2M Buy
25,332
+2,454
+11% +$1.32M 0.53% 75
2023
Q1
$13.2M Buy
22,878
+9,073
+66% +$5.11M 0.55% 68
2022
Q4
$7.6M Sell
13,805
-32
-0.2% -$17K 0.32% 95
2022
Q3
$7.02M Sell
13,837
-2,302
-14% -$1.29M 0.3% 102
2022
Q2
$8.77M Buy
16,139
+126
+0.8% +$69.4K 0.37% 98
2022
Q1
$9.46M Sell
16,013
-189
-1% -$109K 0.32% 103
2021
Q4
$10.8M Sell
16,202
-418
-3% -$261K 0.32% 104
2021
Q3
$9.5M Sell
16,620
-98
-0.6% -$53.8K 0.3% 105
2021
Q2
$8.43M Sell
16,718
-30,687
-65% -$14.5M 0.26% 107
2021
Q1
$21.6M Sell
47,405
-3,812
-7% -$1.82M 0.72% 55
2020
Q4
$23.9M Sell
51,217
-10,030
-16% -$4.7M 0.83% 41
2020
Q3
$27M Buy
61,247
+2,959
+5% +$1.22M 1.2% 18
2020
Q2
$21.1M Buy
58,288
+5,324
+10% +$1.78M 1.02% 28
2020
Q1
$15M Sell
52,964
-1,764
-3% -$556K 0.97% 34
2019
Q4
$17.8M Sell
54,728
-2,777
-5% -$842K 0.84% 44
2019
Q3
$16.7M Sell
57,505
-168
-0.3% -$48.1K 0.87% 42
2019
Q2
$16.9M Buy
57,673
+149
+0.3% +$41K 0.91% 36
2019
Q1
$15.7M Sell
57,524
-261
-0.5% -$65K 0.89% 41
2018
Q4
$12.9M Sell
57,785
-1,654
-3% -$388K 0.95% 33
2018
Q3
$14.5M Sell
59,439
-4,418
-7% -$1.02M 0.83% 52
2018
Q2
$13.2M Sell
63,857
-1,633
-2% -$347K 0.84% 58
2018
Q1
$13.5M Sell
65,490
-15,182
-19% -$3.19M 0.9% 44
2017
Q4
$15.3M Sell
80,672
-1,733
-2% -$332K 0.97% 30
2017
Q3
$15.6M Buy
82,405
+2,943
+4% +$533K 0.97% 30
2017
Q2
$13.9M Sell
79,462
-8,093
-9% -$1.36M 0.93% 26
2017
Q1
$13.4M Sell
87,555
-2,633
-3% -$402K 0.92% 22
2016
Q4
$12.7M Buy
90,188
+10,649
+13% +$1.57M 0.94% 18
2016
Q3
$12.7M Buy
79,539
+13,458
+20% +$2.07M 0.94% 17
2016
Q2
$9.76M Buy
66,081
+266
+0.4% +$39.3K 0.77% 38
2016
Q1
$9.32M Sell
65,815
-1,902
-3% -$255K 0.84% 28
2015
Q4
$9.61M Buy
67,717
+3,344
+5% +$446K 0.87% 22
2015
Q3
$7.87M Sell
64,373
-324
-0.5% -$42.2K 0.76% 36
2015
Q2
$8.39M Sell
64,697
-2,779
-4% -$362K 0.78% 32
2015
Q1
$9.06M Buy
67,476
+71
+0.1% +$9.15K 0.78% 31
2014
Q4
$8.45M Sell
67,405
-5,386
-7% -$655K 0.95% 22
2014
Q3
$8.86M Sell
72,791
-4,093
-5% -$498K 1.21% 21
2014
Q2
$9.07M Buy
76,884
+12,139
+19% +$1.43M 1.29% 22
2014
Q1
$7.79M Buy
64,745
+53,095
+456% +$6.31M 1.21% 27
2013
Q4
$1.3M Buy
11,650
+200
+2% +$19.9K 0.2% 118
2013
Q3
$1.05M Hold
11,450
0.17% 121
2013
Q2
$969K Buy
+11,450
New +$953K 0.17% 118

Other funds holding TMO

Granite Investment Partners's TMO Position: Q1 2026 in Review

Granite Investment Partners increased its Thermo Fisher Scientific (TMO) stake by 0.9% in Q1 2026, buying an estimated $53.7K and bringing the position to 11,098 shares worth $5.46M. The position accounts for 0.34% of the portfolio, ranked #102.

Granite Investment Partners first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $27M in Q3 2020. 2,590 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Granite Investment Partners held 11,098 shares of Thermo Fisher Scientific worth $5.46M as of Q1 2026.
  • Granite Investment Partners bought 99 Thermo Fisher Scientific shares in Q1 2026, an estimated $53.7K.
  • Thermo Fisher Scientific made up 0.34% of Granite Investment Partners's portfolio in Q1 2026, its #102 holding.
  • Granite Investment Partners first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • Granite Investment Partners's Thermo Fisher Scientific position peaked at $27M in Q3 2020.
  • 2,590 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Granite Investment Partners's 13F filing for Q1 2026, filed 30 Apr 2026.